HCC: Novel Anti-PD-1 Agent May Reduce Fatigue, Improve Physical Functioning
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Nursing, Medicine, Healthcare Management
Internal Medicine, Oncology
price
On Book
HCC: Novel Anti-PD-1 Agent May Reduce Fatigue, Improve Physical Functioning is organized by Projects In Knowledge Inc. (PIK) and will be held from Jan 22, 2023 - Jan 21, 2024.
Learning Objective(s):
Evaluate the latest clinical trial data regarding novel tyrosine kinase inhibitors (TKIs), immune checkpoint inhibitors (ICIs), anti-vascular endothelial growth factor (VEGF) agents, and emerging combinations for the treatment of advanced HCC.
Be aware of currently recommended frontline treament options for patients with unresectable HCC.
Additional details will be posted as soon as information is available.